Sophia Genetics, a specialist in data-driven medicine, has raised $13.75m in its series B. The round was led by Invoke Capital, which was joined by Swisscom and Endeavour Vision.
Apart from the cash injection, Sophia gains access to Invoke’s portfolio company Genalys, which uses big data mathematics to analyse genomic information.
Spun out of the Federal Institute of Technology Lausanne in 2011, the Swiss company’s technology makes it possible to diagnose genetic diseases and the DNA of cancer…